# Camp4 Therapeutics Corp: Form SCHEDULE 13D/A, filed Sep 11, 2025

- Company: [Camp4 Therapeutics Corp](/companies/camp.md) (CIK 1736730)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-11
- Accepted by EDGAR: Sep 11, 2025, 16:25 ET
- Period: not reported
- Accession: 0001415889-25-024279
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736730/000141588925024279/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736730/000141588925024279/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736730/000141588925024279/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-024279. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.